Peptide receptor radionuclide therapy improves survival in patients who progress after resection of gastroenteropancreatic neuroendocrine tumors

Luis C. Borbon; Scott K. Sherman; Patrick Breheny; Po H. Ear; Yusuf Menda; Chandrikha Chandrasekharan; Andrew M. Bellizzi; Thomas M. O'Dorisio; Joseph S. Dillon; James R Howe

doi:10.1530/endoabs.98.C46

Abstract

Peptide receptor radionuclide therapy improves survival in patients who progress after resection of gastroenteropancreatic neuroendocrine tumors

Luis C. Borbon, Scott K. Sherman, Patrick Breheny, Po H. Ear, Yusuf Menda, Chandrikha Chandrasekharan, Andrew M. Bellizzi, Thomas M. O'Dorisio, Joseph S. Dillon and James R Howe

Endocrine Abstracts, Vol.98, p.C46

12/15/2023

DOI: 10.1530/endoabs.98.C46

View Online

Abstract

Abstract only

Details

Title: Subtitle: Peptide receptor radionuclide therapy improves survival in patients who progress after resection of gastroenteropancreatic neuroendocrine tumors
Creators: Luis C. Borbon
Scott K. Sherman
Patrick Breheny
Po H. Ear
Yusuf Menda
Chandrikha Chandrasekharan
Andrew M. Bellizzi
Thomas M. O'Dorisio
Joseph S. Dillon
James R Howe
Resource Type: Abstract
Publication Details: Endocrine Abstracts, Vol.98, p.C46
DOI: 10.1530/endoabs.98.C46
ISSN: 1479-6848
eISSN: 1479-6848
Language: English
Date published: 12/15/2023
Academic Unit: Pathology; Radiology; Internal Medicine; Biostatistics; Hematology, Oncology, and Blood & Marrow Transplantation; Fraternal Order of Eagles Diabetes Research Center; Radiation Oncology; Surgery; Endocrinology and Metabolism
Record Identifier: 9984539531802771

Metrics

3 Record Views